Why Teva Pharmaceutical Industries Fell Today

·2 min read
Why Teva Pharmaceutical Industries Fell Today

Teva Pharmaceutical Industries (NYSE: TEVA) was an underperforming stock on Wednesday, and it wasn't hard to discern the reason why. The company's latest quarterly figures came in below analyst expectations, and investors punished the shares by driving them down by nearly 5% on the day. For its third quarter, the results of which were unveiled that morning, Teva earned revenue of $3.9 billion.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting